[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335838-105":59,"doc-detail-335838-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-analyses-of-the-associations-between-109-pre-existing-conditions-and-cancer-treatment-patterns-across-19-adult-cancers","Pan‑cancer analyses of the associations between 109 pre‑existing conditions and cancer treatment patterns across 19 adult cancers","","Comorbidities complicate cancer care, yet evidence on how specific pre-existing conditions shape treatment decisions across cancer types and modalities remains limited. Using a cohort of 280,543 patients across 19 adult cancers, the study quantified pan-cancer frequencies of 109 comorbidities and modelled their links to treatment choices. Multinomial regression assessed treatment types, while binomial regression evaluated associations with chemotherapy drug classes, adjusting for demographic and clinical factors. Results show comorbidity is consistently associated with lower likelihood of chemotherapy and multimodality care. Multi-specialty collaborative management is emphasized, including strategies to address toxicity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-analyses-of-the-associations-between-109-pre-existing-conditions-and-cancer-treatment-patterns-across-19-adult-cancers/335838/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-analyses-of-the-associations-between-109-pre-existing-conditions-and-cancer-treatment-patterns-across-19-adult-cancers/335838.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about comorbidities and cancer care?","Question",{"text":112,"@type":113},"It investigates how 109 pre-existing comorbidities are associated with cancer treatment decisions across 19 adult cancer types and multiple treatment patterns, including chemotherapy and surgery.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were associations between comorbidities and treatment patterns analyzed?",{"text":117,"@type":113},"The study used multinomial logistic regression for treatment types and binomial logistic regression for chemotherapy drug classes, adjusting for demographic and clinical factors.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the main pattern observed regarding treatment and comorbidity?",{"text":121,"@type":113},"Patients with comorbidity had lower odds of receiving chemotherapy and multimodality treatment, and comorbidity was consistently linked to reduced chemotherapy use across drug classes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335838,1790114848,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPan‑cancer analyses  \nof the associations between 109 pre‑existing conditions and cancer treatment patterns across 19 adult cancers  \nWai Hoong Chang* & AlvinaG. Lai *  \nComorbidities present considerable challenges to cancer treatment and care. However, little is known about the effect of comorbidity on cancer treatment decisions across a wide range of cancer types and treatment modalities. Harnessing a cohort of 280,543 patients spanning 19 site‑specific cancers, we explored pan‑cancer frequencies of 109 comorbidities. Multinomial logistic regression was used to analyse the relationship between comorbidities and cancer treatment types, while binomial logistic regression examined the association between comorbidities and chemotherapy drug types, adjusting for demographic and clinical factors. Patients with comorbidity exhibited lower odds of receiving chemotherapy and multimodality treatment. End‑stage renal disease was significantly associated with a decreased odds of receiving chemotherapy and surgery. Patients with prostate cancer who have comorbid non‑acute cystitis, obstructive and reflux uropathy, urolithiasis, or hypertension were less likely to receive chemotherapy. Among patients with breast cancer, dementia, left bundle branch block, peripheral arterial disease, epilepsy, Barrett’s oesophagus, ischaemic stroke, unstable angina and asthma were associated with lower odds of receiving multimodal chemotherapy, radiotherapy and surgery. Comorbidity is also consistently associated with the lower odds of receiving chemotherapy when comparing across 10 drug classes. Patients with comorbid dementia, intracerebral haemorrhage, subarachnoid haemorrhage, oesophageal varices, liver fibrosis sclerosis and cirrhosis and secondary pulmonary hypertension were less likely to receive antimetabolites. Comorbidity can influence the effectiveness and tolerability of cancer treatment and ultimately, prognosis. Multi‑specialty collaborative care is essential for the management of comorbidity during cancer treatment, including prophylactic measures to manage toxicities.  \nPatients with cancer do not usually have cancer alone. Comorbidities present challenges to cancer treatment because they influence treatment decisions, prognosis and the overall trajectory of care. Yet, the influence of specific comorbidities at various points of the cancer care pathway is not well understood. Certain comorbidities might not directly influence survival but could affect patients’ tolerability to treatment. Cancer therapy could also exacerbate pre-existing conditions or give rise to new comorbidities due to treatment-related toxicities. In the UK, the National Institute for Health and Care Excellence (NICE) guidelines for cancer management have limited information on comorbidities. The guideline for lung cancer briefly mentioned that radiotherapy with curative intent should consider the presence ofcomorbidities1. The NICE breast cancer guideline stated that patients with invasive breast cancer should be treated with surgery and systemic therapy, irrespective of age unless significant comorbidity precludes surgery2. There is no mention of what significant comorbidity entails. The guideline also recommends offering trastuzumab to patients with invasive breast cancer and to consider comorbidities but did not specify which comorbidities to consider nor did it mention how comorbidities should be managed during cancer treatment. Similarly, the prostate cancer guidelines stated that docetaxel chemotherapy should only be offered to patients who do not have significant comorbidities but did not mention specific comorbidities3.  \nInstitute of Health Informatics, University College London, London, UK.* email: [changwaihoong@gmail.com](changwaihoong@gmail.com); [alvinagracelai@gmail.com](alvinagracelai@gmail.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nGu","cbCaihc0SMTdjscW","https://ap.wps.com/l/cbCaihc0SMTdjscW","pdf",1207051,13,"English","# Abstract\n## Study cohort and methods\n## Key findings on treatment decisions\n## Implications for care coordination","[{\"question\":\"What question does the study address about comorbidities and cancer care?\",\"answer\":\"It investigates how 109 pre-existing comorbidities are associated with cancer treatment decisions across 19 adult cancer types and multiple treatment patterns, including chemotherapy and surgery.\"},{\"question\":\"How were associations between comorbidities and treatment patterns analyzed?\",\"answer\":\"The study used multinomial logistic regression for treatment types and binomial logistic regression for chemotherapy drug classes, adjusting for demographic and clinical factors.\"},{\"question\":\"What is the main pattern observed regarding treatment and comorbidity?\",\"answer\":\"Patients with comorbidity had lower odds of receiving chemotherapy and multimodality treatment, and comorbidity was consistently linked to reduced chemotherapy use across drug classes.\"}]","Pan‑cancer analyses of the associations between 109 pre‑existing conditions and cancer treatment patterns across 19 adult cancers | PDF",1790012524,33]